Home
Product

Escherichia coli Nissle 1917 EVs

Unlike pathogenic E. coli, these EVs are derived from a safe probiotic strain used to deliver therapeutic cargo to the gut. Research applications include vaccine delivery platforms and treating intestinal inflammation.

Microbial Extracellular Vesicle

CAT#	Product Name	Product Overview	Datasheet	SIZE	PRICE	Add to basket
LBGF-0326-GF49	Escherichia coli Nissle 1917 derived Extracellular Vesicles (EVs)	This product consists of purified extracellular vesicles (EVs) harvested from the culture supernatant of Escherichia coli Nissle 1917. These vesicles are biogenic, lipid-bilayered nanostructures that play a critical role in intercellular communication, immune modulation, and host-microbe interactions. Unlike live probiotics, these EVs are non-replicating, making them a "postbiotic" component suitable for research into targeted delivery, vaccine development, and therapeutic signaling.				Inquiry

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.

ISO 9001 Certified - Creative Biolabs Quality Management System.

Tel:
Fax:
Email:
Global